Long-term outcome of Guillain-Barré syndrome in children

Journal of the Peripheral Nervous System

Volumn 19, Issue 2, 2014, Pages 121-126

  Roodbol, Joyce ^a   De Wit, Marie Claire Y ^a   Aarsen, Femke K ^a   Catsman Berrevoets, Coriene E ^a   Jacobs, Bart C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Follow up; Guillain Barr syndrome; Outcome; Paediatric neurology

Indexed keywords

IMMUNOGLOBULIN; COLESTYRAMINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMOTION; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; GAIT; GUILLAIN BARRE SYNDROME; HUMAN; INFANT; LIMB WEAKNESS; MALE; OBSERVATIONAL STUDY; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SHORT FORM 36; SOCIAL INTERACTION; STRUCTURED INTERVIEW; UNSTEADINESS; BEHAVIOR; COMPLICATION; DISEASE COURSE; ETIOLOGY; GUILLAIN-BARRE SYNDROME; HANDICAPPED CHILD; NETHERLANDS; NEUROLOGIC EXAMINATION; NEWBORN; PRESCHOOL CHILD; PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; BEHAVIORAL SYMPTOMS; CHILD; CHILD, PRESCHOOL; CHOLESTYRAMINE RESIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABLED CHILDREN; DISEASE PROGRESSION; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; NEUROLOGIC EXAMINATION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84925354428     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns5.12068     Document Type: Article

References (25)

1. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055-1068.
2. Achenbach TM, Becker A, Dopfner M, Heiervang E, Roessner V, Steinhausen HC, Rothenberger A (2008). Multicultural assessment of child and adolescent psychopathology with ASEBA and SDQ instruments: research findings, applications, and future directions. J Child Psychol Psychiatry 49:251-275.
3. Asbury AK, Cornblath DR (1990). Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 27(Suppl):S21-S24.
4. Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 67:588-597.
5. Bernsen RA, de Jager AE, Schmitz PI, van der Meche FG (2002). Long-term impact on work and private life after Guillain-Barre syndrome. J Neurol Sci 201:13-17.
6. van Doorn PA, Ruts L, Jacobs BC (2008). Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 7:939-950.
7. Dornonville de la Cour C, Andersen H, Stalberg E, Fuglsang-Frederiksen A, Jakobsen J (2005). Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barre syndrome. Muscle Nerve 31:70-77.
8. Drenthen J, Jacobs BC, Maathuis EM, van Doorn PA, Visser GH, Blok JH (2013). Residual 3 fatigue in Guillain-Barre syndrome is related to axonal loss. Neurology 81:1827-1831.
9. Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA (2004). Physical training and fatigue, fitness, and quality of life in Guillain-Barre syndrome and CIDP. Neurology 63:2393-2395.
10. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998). Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 44:780-788.
11. Harila MJ, Salo J, Lanning M, Vilkkumaa I, Harila-Saari AH (2010). High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 55:331-336.
12. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978). Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750-753.
13. Korinthenberg R, Schessl J, Kirschner J (2007). Clinical presentation and course of childhood Guillain-Barre syndrome: a prospective multicentre study. Neuropediatrics 38:10-17.
14. McGrogan A, Madle GC, Seaman HE, de Vries CS (2009). The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150-163.
15. van der Meché FGA, van Doorn PA, Meulstee J, Jennekens FGI, for the GBS consensus group of the Dutch Neuromuscular Research Support (2001). Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol 45:133-139.
16. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA (1999). Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648-1654.
17. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA, Inflammatory Neuropathy Cause Treatment group (2002). Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596-601.
18. Nagasawa K, Kuwabara S, Misawa S, Fujii K, Tanabe Y, Yuki N, Hattori T, Kohno Y (2006). Electrophysiological subtypes and prognosis of childhood Guillain-Barre syndrome in Japan. Muscle Nerve 33:766-770.
19. Ortiz-Corredor F, Peña-Preciado M (2007). Use of immunoglobulin in severe childhood Guillain-Barre syndrome. Acta Neurol Scand 115:289-293.
20. Rabie M, Nevo Y (2009). Childhood acute and chronic immune-mediated polyradiculoneuropathies. Eur J Paediatr Neurol 13:209-218.
21. Rekand T, Gramstad A, Vedeler CA (2009). Fatigue, pain and muscle weakness are frequent after Guillain-Barre syndrome and poliomyelitis. J Neurol 256:349-354.
22. Rudolph T, Larsen JP, Farbu E (2008). The long-term functional status in patients with Guillain-Barre syndrome. Eur J Neurol 15:1332-1337.
23. Schessl J, Koga M, Funakoshi K, Kirschner J, Muellges W, Weishaupt A, Gold R, Korinthenberg R (2007). Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndrome. Arch Dis Child 92:48-52.
24. Vajsar J, Fehlings D, Stephens D (2003). Long-term outcome in children with Guillain-Barre syndrome. J Pediatr 142:305-309.
25. Verrips GH, Vogels AG, den Ouden AL, Paneth N, Verloove-Vanhorick SP (2000). Measuring health-related quality of life in adolescents: agreement between raters and between methods of administration. Child Care Health Dev 26:457-469.